BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23793015)

  • 1. Percutaneous treatment of paravalvular leaks after transcatheter aortic valve implantation with the CoreValve self-expanding bioprosthesis.
    Saia F; Marrozzini C; Moretti C; Bordoni B; Ciuca C; Marzocchi A
    EuroIntervention; 2013 Jun; 9(2):292. PubMed ID: 23793015
    [No Abstract]   [Full Text] [Related]  

  • 2. Difficulties with horizontal aortic root in transcatheter aortic valve implantation.
    Chan PH; Alegria-Barrero E; Di Mario C
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):630-5. PubMed ID: 22431290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous closure of paravalvular leak after transcatheter aortic valve replacement.
    Luu J; Ali O; Feldman TE; Price MJ
    JACC Cardiovasc Interv; 2013 Feb; 6(2):e6-8. PubMed ID: 23428021
    [No Abstract]   [Full Text] [Related]  

  • 4. Transcatheter aortic valve implantation for treatment of failing homograft with preexisting mechanical mitral prosthesis.
    Attia R; Bapat V
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):324-7. PubMed ID: 22120953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balloon valuloplasty prior to transcatheter valve-in-valve implantation in a degenerated Mitroflow aortic bioprosthesis.
    Cerillo AG; Berti S; Glauber M
    Catheter Cardiovasc Interv; 2013 May; 81(6):1075-8. PubMed ID: 22744728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transseptal approach for the management of paravalvular regurgitation after transcatheter aortic valve replacement.
    Martinez CA; O'Neill B; Singh V; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E587-91. PubMed ID: 23008182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CoreValve aortic bioprosthesis: repositioning techniques.
    Vavuranakis M; Vrachatis D; Stefanadis C
    JACC Cardiovasc Interv; 2010 May; 3(5):565; author reply 565-6. PubMed ID: 20488417
    [No Abstract]   [Full Text] [Related]  

  • 8. Two-stage percutaneous closure of paravalvular leak in a patient with stentless aortic bioprosthesis.
    Smolka G; Pysz P; Jasinski M
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):E119-23. PubMed ID: 22581510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-in-human valve-in-valve implantation of a 20 mm balloon expandable transcatheter heart valve.
    Binder RK; Wood D; Webb JG; Cheung A
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E929-31. PubMed ID: 22821872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential CoreValve implantation for a mal-positioned prosthesis during transcatheter aortic valve implantation.
    Ong SH; Mueller R; Gerckens U
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):1071-5. PubMed ID: 21413126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CoreValve degeneration with severe transvalvular aortic regurgitation treated with valve-in-valve implantation.
    Sinning JM; Vasa-Nicotera M; Werner N; Zimmer S; Mellert F; Welz A; Grube E; Nickenig G; Hammerstingl C
    JACC Cardiovasc Interv; 2014 Jul; 7(7):e71-2. PubMed ID: 24954574
    [No Abstract]   [Full Text] [Related]  

  • 12. Impingement of left main ostium after device occlusion of paravalvular leak post-transcatheter aortic valve replacement.
    Price MJ; Shah MG; Burke RF; Riley RD; Rizik DG
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e1-2. PubMed ID: 25616835
    [No Abstract]   [Full Text] [Related]  

  • 13. Paravalvular regurgitation after transcatheter aortic valve replacement: diagnosis, clinical outcome, preventive and therapeutic strategies.
    Dvir D; Barbash IM; Ben-Dor I; Torguson R; Badr S; Minha S; Pendyala LK; Loh JP; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2013; 14(3):174-81. PubMed ID: 23773501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symetis ACURATE TA valve.
    Kempfert J; Möllmann H; Walther T
    EuroIntervention; 2012 Sep; 8 Suppl Q():Q102-9. PubMed ID: 22995104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valve-in-valve-in-valve transcatheter aortic valve implantation to treat a degenerated surgical bioprosthesis in a subaortic position.
    Nuis RJ; Benitez LM; Nader CA; Perez S; de Marchena EJ; Dager AE
    Tex Heart Inst J; 2013; 40(3):323-5. PubMed ID: 23914032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of aortic regurgitation after transcatheter aortic valve implantation.
    Jilaihawi H; Makkar RR
    EuroIntervention; 2012 Sep; 8 Suppl Q():Q31-3. PubMed ID: 22995109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful percutaneous paravalvular leak closure followed by transfemoral aortic lotus valve-in-valve implantation in a degenerated surgical bioprosthesis.
    Nerla R; Cremonesi A; Castriota F
    Catheter Cardiovasc Interv; 2018 Jan; 91(1):169-174. PubMed ID: 27143596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-emptive positioning of a coronary stent in the left anterior descending artery for left main protection: a prerequisite for transcatheter aortic valve-in-valve implantation for failing stentless bioprostheses?
    Chakravarty T; Jilaihawi H; Nakamura M; Kashif M; Kar S; Cheng W; Makkar R
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E630-6. PubMed ID: 23729203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Device closure of paravalvular defects following transcatheter aortic valve replacement with the Edwards Sapien valve.
    Whisenant B; Jones K; Horton KD; Horton S
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):901-5. PubMed ID: 22581786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation.
    Hayashida K; Lefèvre T
    EuroIntervention; 2012 Sep; 8 Suppl Q():Q34-40. PubMed ID: 22995110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.